| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $310.5M | — | +41.5% |
| Cost of Revenue | $242.2M | — | +19.9% |
| Gross Profit | $68.3M | — | +289.4% |
| R&D Expense | $50.2M | — | -19.1% |
| SG&A Expense | $36.4M | — | +20.7% |
| Operating Income | -$55.0M | — | +46.4% |
| Pre-tax Income | -$56.1M | — | +39.4% |
| Income Tax | $1.3M | — | -77.5% |
| Net Income | -$57.4M | — | +41.8% |
| EPS (Basic) | -$0.95 | — | +44.1% |
| EPS (Diluted) | -$0.95 | — | +44.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $512.4M | +12.6% | +27.7% |
| Short-term Investments | $29.3M | -23.2% | -88.3% |
| Accounts Receivable | $222.7M | -16.7% | +68.0% |
| Inventory | $596.8M | +8.0% | -6.2% |
| Current Assets | $1.82B | +4.4% | -8.7% |
| Total Assets | $2.26B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.4M | — | -27.8% |
| Capital Expenditures | $3.7M | — | -63.4% |
| Investing Cash Flow | -$20.4M | — | -130.2% |
| Financing Cash Flow | $2.0M | — | +131.9% |
| Free Cash Flow | $20.7M | — | -12.6% |
| -10.5% |
| Current Liabilities | $897.3M | +11.7% | -7.9% |
| Stockholders' Equity | $410.7M | -3.9% | -30.9% |